Spike Team S2 Ep 25

Recombinant DENV EP Protein [His] (Drosophila S2)

VAng-Wyb8610-inquire inquire Ask for price
Description: Dengue virus Type 4 Envelope Protein (aa 280-674), recombinant protein from Drosophila S2, 2.54 mg/mL.

Human IgG antibody Laboratories manufactures the spike team s2 ep 25 reagents distributed by Genprice. The Spike Team S2 Ep 25 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S2. Other Spike products are available in stock. Specificity: Spike Category: Team Group: S2 Ep

Human True insulin ELISA kit

1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True Insulin GENLISA ELISA

1 x 96 wells
EUR 286

Human True insulin ELISA kit

96T
EUR 700
Description: ELISA

Rabbit IgG Anti SARS-CoV-2 Spike (S2) Polyclonal Antibody

0.1
EUR 405.69
Description: Rabbit polyclonal to SARS-CoV-2 spike glycoprotein subunit 2 (S2).

Rabbit IgG Anti SARS-CoV-2 Spike (S2) Polyclonal Antibody

0.5
EUR 1259.17
Description: Rabbit polyclonal to SARS-CoV-2 spike glycoprotein subunit 2 (S2).

human-anti-2019-nCoV-S2-mAb(S2)

2019-nCoV-Recombinant-Antibody(-eiptope-around-770-820aa),humanized-S-IgG,gram-level-production
EUR 416.5
Description: 2019-nCoV Recombinant Antibody ( eiptope around 770-820aa) , humanized S IgG, gram level production

S2 Ep information

Spike Trimer (S1+S2), His-tag (SARS-CoV-2)

100728-2 1 mg
EUR 2995
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), with 682RRAR685>A, K986P, and V987P mutations, Genbank Accession No. MN908947, a.a. 1-1213, with a C-terminal His-tag, expressed in a HEK293 expression system. MW=139 kDa.

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (0018)

MAB12421-50 0.05
EUR 588.13
Description: Mouse monoclonal antibody against SARS-CoV-2 glycoprotein Spike S2.

SARS-CoV-2 (COVID-19) Spike S2 Antibody [5E6]

PM-9429-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike S2 Antibody [5E6]

PM-9429-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (CH1)

MAB12447-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (CH1)

MAB12447-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (JC7)

MAB12449-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (JC7)

MAB12449-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

SARS-CoV-2 (COVID-19) Spike S2 Antibody [4F10]

PM-9428-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike S2 Antibody [4F10]

PM-9428-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (AD10)

MAB12446-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (AD10)

MAB12446-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (HA11)

MAB12448-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (HA11)

MAB12448-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A6]

SD9785-002mg 0.02 mg
EUR 253.22
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A6]

SD9785-01mg 0.1 mg
EUR 723.62
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1B8]

SD9787-002mg 0.02 mg
EUR 253.22
Description: N/A